968 / 1578
•
SBRT competitive to RFA and SIRT in inoperable HCC
•
Prognostic factors
•
C-P Score, tumor size, s-AFP and PVT
•
Risk of liver failure in C-P B (low) and C-P C (high) HCC
patients
Conclusions – SBRT of abdomino-pelvic
oligometastases
Conclusions – SBRT of primary liver cancer